N6-methyladenosine (m6A) serves as a critical RNA modification, dynamically governing RNA metabolism through its influence on RNA stability, splicing, ...

A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary ...

The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.

A study published in Experimental Gerontology has found that low doses of THC may help improve wound healing in older ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...

The financing was accomplished under a private placement with a select number of investors. This funding builds upon CoRegen’s prior $28 million raise in early 2024, which supported the acquisition of ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.

Research led by the Joldasbekov Institute of Mechanics and Engineering in Kazakhstan, reports that camel milk intake ...

A new machine learning approach identifies cellular senescence at single-cell resolution across varying cell types and tissue ...

CD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the hostile and chronic environment of tumors, these cells often falter.

Adenosine deaminase 2 (ADA2) plays a critical role in immune regulation, particularly in monocyte differentiation and ...